Source:http://linkedlifedata.com/resource/pubmed/id/21530767
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:dateCreated |
2011-5-2
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Apr
|
| pubmed:issn |
1532-8686
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
48 Suppl 1
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
S1-3
|
| pubmed:meshHeading | |
| pubmed:year |
2011
|
| pubmed:articleTitle |
The evolving role of bendamustine in lymphoid malignancy: understanding the drug and its mechanism of action--introduction.
|
| pubmed:affiliation |
Actus Advisory, Lugano, Switzerland. lleoni@actus-advisory.com
|
| pubmed:publicationType |
Introductory Journal Article
|